Connection

Jean Reignier to Antiviral Agents

Back to Details
This is a "connection" page, showing publications Jean Reignier has written about Antiviral Agents.
Jean Reignier
Connection Strength
0.022
Antiviral Agents
  1. An open-label randomized controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-ß-1a and hydroxychloroquine in hospitalized patients with COVID-19. Clin Microbiol Infect. 2021 Dec; 27(12):1826-1837.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.